Safety of venetoclax quick dose escalation within CLL sufferers in the past treated with Bcell receptor signaling antagonists: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 January 2024

  • curprev 18:3418:34, 18 January 2024‎ Slashlathe9 talk contribs‎ 3,667 bytes +3,667‎ Created page with "Young children mentioned regarding KD involving 2011-2014 inside 65 centers were registered. Aspects associated with subsequent line-treatment; my spouse and i.electronic. unresponsiveness to be able to preliminary IVIg remedy, ended up reviewed by simply multivariate regression examination. The performance individuals rating as well as the Kobayashi, Egami and also Sano scores were in contrast inside our inhabitants plus cultural subgroups. All round, 465 youngsters had..."
Retrieved from "https://news.npo.digital/index.php?title=Safety_of_venetoclax_quick_dose_escalation_within_CLL_sufferers_in_the_past_treated_with_Bcell_receptor_signaling_antagonists"